Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001638599-20-000681

Options or other derivatives

  • Director acquired 1,428,572 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BAKER BROS. ADVISORS LP · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-07-24 Grant or award : show line 1 in the form Class A1 Common Shares +93,210 $21.00 $1,957,410 1,143,650 I
2020-07-24 Grant or award : show line 2 in the form Class A1 Common Shares +1,335,362 $21.00 $28,042,602 11,638,314 I
Loading xslF345X03/doc4_6800.xml…